Division of Dermatology, McGill University Health Center, Montreal, Quebec, Canada; Department of Dermatology, University of New York Downstate and Veterans Affairs Medical Center, Brooklyn, New York.
Division of Dermatology, McGill University Health Center, Montreal, Quebec, Canada; Department of Dermatology, University of New York Downstate and Veterans Affairs Medical Center, Brooklyn, New York.
J Am Acad Dermatol. 2021 Jul;85(1):152-161. doi: 10.1016/j.jaad.2020.09.052. Epub 2020 Oct 1.
Few data exist to guide the application of Mohs micrographic surgery (MMS) in the pediatric population.
We sought to summarize the clinical characteristics of children undergoing MMS, identify challenges that limit the use of MMS in this population, and examine how these challenges can be overcome.
A systematic review of PubMed and EMBASE, from inception of databases to November 2, 2019, identified all cases of pediatric skin lesions treated with MMS.
A total of 111 patients were included. The median patient age was 11 years (range 6 weeks to 17 years). The most commonly treated tumor was dermatofibrosarcoma protuberans (n = 62), followed by basal cell carcinoma (n = 30). The most common location was the head and neck (n = 34), followed by the trunk (n = 28) and the extremities (n = 23). The most commonly cited challenges in the application of MMS in children included patient cooperation, concerns for the safety of prolonged general anesthesia, availability of a MMS service in the pediatric setting, and access to a histopathology laboratory experienced in MMS sectioning.
Many articles did not report specific patient characteristics.
Multiple obstacles limit the application of MMS in pediatric patients. This review describes practical methods to circumvent these obstacles to facilitate the appropriate use of MMS in children.
指导儿童人群应用Mohs 显微外科手术(MMS)的相关数据有限。
我们旨在总结接受 MMS 治疗的儿童患者的临床特征,明确限制该技术在该人群中应用的挑战,并探讨如何克服这些挑战。
对 PubMed 和 EMBASE 数据库进行了系统性回顾,检索时间为数据库建立至 2019 年 11 月 2 日,纳入所有接受 MMS 治疗的儿童皮肤病变病例。
共纳入 111 例患者。患者中位年龄为 11 岁(范围 6 周至 17 岁)。最常治疗的肿瘤为隆突性皮肤纤维肉瘤(n = 62),其次为基底细胞癌(n = 30)。最常见的部位是头颈部(n = 34),其次是躯干(n = 28)和四肢(n = 23)。在儿童人群中应用 MMS 时,最常提到的挑战包括患者配合、对长时间全身麻醉安全性的担忧、儿科环境中是否有 MMS 服务以及能否找到有 MMS 切片经验的组织病理学实验室。
许多文章未报告具体的患者特征。
多项障碍限制了 MMS 在儿科患者中的应用。本综述描述了克服这些障碍的实用方法,以促进 MMS 在儿童中的合理应用。